The global point of care (PoC) lipid test market was estimated at USD 200 million in 2014. Growing occurrence of target ailments, such as diabetes, dyslipidemia, and cardiovascular diseases, is one of the major driving factors. The presence of regulatory programs regarding diagnosis is said to act as a high impact rendering driver.
Increasing elderly population base along with rising awareness levels is projected to drive the market growth. Plus, increasing demand for technological developments to improve user-friendliness, accuracy, speed etc. are projected to boost the market demand. Due to an increase in sedentary routine & unhealthy lifestyle habits, manufacturers are expected to have a continually expanding user-base.
Full research report on point of care (PoC) lipid test market analysis:
Samsung LABGEO PT10, Roche Reflotron, Alere Cholestech LDx, Abaxis Piccolo are some of the most used instruments set. Alere Cholestech LDX accounted for over USD 55 million of the total shares and thus is said to augment the Cholestech LDX adoption rates for daily lipid level checking & home usage.
Roche Cobas B101 is projected to witness a tremendous demand growth and is expected to grow at a CAGR rate of 24%. The primary market growth drivers include upcoming advanced technologies and the advent of CLIA waived tests related to point of care molecular diagnostics.
Request for sample of this research report:
The market is divided into hypertriglyceridemia, hyperlipidemia, Tangier disease, hyperlipoproteinemia, and others, based on its applications. Hyperlipidemia dominated the global market with the market value of over USD 55 million in 2014. Increasing occurrence of hyperlipidemia and an increased point of care equipment demand are the aspects responsible for the biggest share of the sector. Moreover, this application sector is projected to grow at the highest CAG rate of 5.7% in the near future.
In 2014, Europe accounted for the biggest market share of about 35% mainly because of high occurrence levels of diseases and the presence of favorable government programs pertaining to the healthcare infrastructure development. Asia-Pacific is projected to show high growth potential with a CAG rate of over 10% mainly because of growing population with diabetes, cardiovascular disease etc. and favorable regulatory landscape. Australia, China, Brazil, and South Africa are witnessing fast growth over the last few years.
Roche Diagnostics, Samsung Electronics Corporation, Polymer Technology Systems, and Abaxis Inc. are some of the major market players.
View more reports of this category by Grand View Research at:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States